Non-Muscle Invasive Bladder Cancer: Difference between revisions
Urology4all (talk | contribs) |
Urology4all (talk | contribs) |
||
| Line 122: | Line 122: | ||
***No chemotherapy trials have achieved a significant reduction in progression | ***No chemotherapy trials have achieved a significant reduction in progression | ||
*'''<span style="color:#ff0000">Reduces risk of tumour recurrence</span>''' | *'''<span style="color:#ff0000">Reduces risk of tumour recurrence</span>''' | ||
** | **'''<span style="color:#ff0000">Number needed to treat to prevent 1 recurrence: 8 (absolute risk reduction ≈12%)''' | ||
***'''<span style="color:#ff00ff">Meta-analysis evaluating immediate intravesical chemotherapy on risk of recurrence</span>''' | ***'''<span style="color:#ff00ff">Meta-analysis evaluating immediate intravesical chemotherapy on risk of recurrence</span>''' | ||
**** 13 studies including 2548 patients | **** 13 studies including 2548 patients | ||